Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,153 | 25,220 | 19,324 | 32,919 | 39,297 |
| Marketable Securities | 2,032 | 2,002 | 1,969 | 1,937 | 3,609 |
| Receivables | 192 | 106 | 45 | 55 | 285 |
| TOTAL | $16,668 | $27,690 | $21,669 | $35,633 | $43,470 |
| Non-Current Assets | |||||
| PPE Net | 525 | 532 | 409 | 392 | 227 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 736 |
| TOTAL | $525 | $532 | $409 | $392 | $963 |
| Total Assets | $17,193 | $28,222 | $22,078 | $36,025 | $44,432 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $3,374 | $6,009 | $7,291 | $6,504 | $2,501 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,374 | $6,009 | $7,291 | $6,504 | $2,501 |
| Shareholders' Equity | |||||
| Common Shares | 237,657 | 228,613 | 198,155 | 0 | 0 |
| Retained earnings | -249,966 | -231,347 | -207,814 | -171,441 | -138,762 |
| Other shareholders' equity | 280 | 457 | 320 | 2,536 | 6,066 |
| TOTAL | $13,819 | $22,213 | $14,787 | $29,520 | $41,932 |
| Total Liabilities And Equity | $17,193 | $28,222 | $22,078 | $36,025 | $44,432 |